In the current study, we chose to evaluate response to perilesional IFNα2b alone, without surgical excision, to determine if this would be a viable treatment alternative in a setting where surgical excision could not first be performed (e.g., a client unable without access to a referral facility, in an ambulatory setting, or a tumor too difficult to resect). This evidence concerns the gene IFNA2 and neoplasm.